← The library
Eptifibatide
Cardio/VascularEvidence grade
AFDA-approved Rx (labeled use)
Cardiovascular · 0–5 · separate axis
4
PurposeAntiplatelet
MechanismGPIIb/IIIa inhibitor (peptide)
EffectsGPIIb/IIIa inhibitor (peptide)
DosingNo human dose established.
Bottom lineStrongest data when used for its labeled indication under clinician guidance.
Batches on filenone
No tested batches on file.
Cautions & interactions
Bleeding/thrombocytopenia risk
High bleeding risk with anticoagulants/antiplatelets/NSAIDs; hospital-only protocols.
CV 4 of 5 — Hospital cardiovascular use with strong clinical evidence for specific acute indications (not wellness).